Biocon Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	24,165	32,271	12,336	13,235	6,630
Short-Term Investments	7,768	8,907	10,248	19,585	20,501
Trading Asset Securities	6,898	4,473	3,156	4,443	2,518
Cash & Short-Term Investments	38,831	45,651	25,740	37,263	29,649
Cash Growth	-14.94%	77.35%	-30.92%	25.68%	-8.03%
Accounts Receivable	59,868	54,879	62,306	35,732	20,582
Other Receivables	1,550	964	389	1,321	4,506
Receivables	61,418	55,843	62,695	37,053	25,759
Inventory	60,857	49,311	49,439	42,437	22,982
Prepaid Expenses	2,424	1,899	1,571	1,316	873
Other Current Assets	8,268	10,158	12,347	5,271	4,560
Total Current Assets	171,798	162,862	151,792	123,340	83,823
Property, Plant & Equipment	146,635	134,141	119,778	101,226	93,643
Long-Term Investments	13,647	6,815	6,843	8,673	3,702
Goodwill	183,775	167,857	163,724	161,362	264
Other Intangible Assets	104,316	102,719	102,867	105,259	12,887
Long-Term Deferred Tax Assets	5,556	2,577	3,173	3,010	2,933
Other Long-Term Assets	10,779	11,002	12,530	17,558	6,688
Total Assets	636,506	587,973	560,707	520,428	203,940

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	67,721	65,487	62,720	38,420	16,085
Accrued Expenses	11,855	9,131	2,906	4,840	1,741
Short-Term Debt	40,784	53,501	27,972	24,802	8,962
Current Portion of Long-Term Debt	-	-	-	-	95
Current Portion of Leases	724	674	547	390	211
Current Income Taxes Payable	4,160	1,731	2,769	2,250	1,618
Current Unearned Revenue	1,277	1,452	1,176	1,915	1,053
Other Current Liabilities	14,171	11,362	55,498	12,490	8,515
Total Current Liabilities	140,692	143,338	153,588	85,107	38,280
Long-Term Debt	107,463	124,054	129,324	152,905	39,985
Long-Term Leases	5,370	5,391	4,924	2,091	2,215
Long-Term Unearned Revenue	4,813	3,366	3,107	2,901	12,151
Pension & Post-Retirement Benefits	1,609	1,214	1,101	1,034	917
Long-Term Deferred Tax Liabilities	2,417	3,577	3,915	3,818	523
Other Long-Term Liabilities	7,927	29,908	12,000	47,684	15,169
Total Liabilities	270,291	310,848	307,959	295,540	109,240

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	8,105	6,003	6,003	6,003	6,003
Additional Paid-In Capital	155,600	2,581	2,285	1,735	1,192
Retained Earnings	141,798	191,469	177,906	162,476	69,890
Treasury Stock	-423	-784	-971	-971	-324
Comprehensive Income & Other	35,238	17,171	12,614	9,426	7,564
Total Common Equity	340,318	216,440	197,837	178,669	84,325
Minority Interest	25,897	60,685	54,911	46,219	10,375
Shareholders' Equity	366,215	277,125	252,748	224,888	94,700
Total Liabilities & Equity	636,506	587,973	560,707	520,428	203,940

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	154,341	183,620	162,767	180,188	51,468
Net Cash (Debt)	-115,510	-137,969	-137,027	-142,925	-21,819
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-84.40	-115.15	-114.49	-119.51	-18.24
Filing Date Shares Outstanding	1,620	1,198	1,197	1,194	1,193
Total Common Shares Outstanding	1,620	1,198	1,197	1,194	1,193
Working Capital	31,106	19,524	-1,796	38,233	45,543
Book Value Per Share	210.14	180.66	165.30	149.64	70.68
Tangible Book Value	52,227	-54,136	-68,754	-87,952	71,174
Tangible Book Value Per Share	32.25	-45.19	-57.45	-73.66	59.66
Land	3,903	3,726	3,373	2,918	2,805
Buildings	29,900	26,492	23,170	20,814	19,766
Machinery	135,080	120,289	103,389	97,262	76,553
Construction In Progress	46,127	41,017	39,852	25,875	34,203
Leasehold Improvements	4,158	3,619	2,686	2,518	116